Summit Trail Advisors’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EMN
Summit Trail Advisors's EMN Position: Q2 2026 in Review
Summit Trail Advisors increased its Eastman Chemical (EMN) stake by 10% in Q2 2026, buying an estimated $156K and bringing the position to 22,579 shares worth $1.51M. The position accounts for 0.02% of the portfolio, ranked #789.
Summit Trail Advisors first reported a position in EMN in Q4 2017 and has held it in 6 quarters since. The position peaked at $1.8M in Q2 2025. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Summit Trail Advisors held 22,579 shares of Eastman Chemical worth $1.51M as of Q2 2026.
- Summit Trail Advisors bought 2,127 Eastman Chemical shares in Q2 2026, an estimated $156K.
- Eastman Chemical made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #789 holding.
- Summit Trail Advisors first reported a position in Eastman Chemical in Q4 2017 and has held it in 6 quarters since.
- Summit Trail Advisors's Eastman Chemical position peaked at $1.8M in Q2 2025.
- 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.